SIERRA SUMMIT ADVISORS LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2012614 INCLINE VILLAGE, NV

Position in REGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$9,152,320

+$8,932,118 QoQ

Shares Held

14,678

+5050.2% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

1.04%

of 13F equity value

Holder Rank

#89

of 626 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SIERRA SUMMIT ADVISORS LLC holds $27,426,154 across 7 Biotechnology names. REGN ranks #2 (33.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	41,684	$12,548,134
2	REGN	Regeneron Pharmaceuticals, Inc. This page	14,678	$9,152,320
3	RIGL	Rigel Pharmaceuticals Inc	31,876	$1,246,989
4	BMRN	Biomarin Pharmaceutical Inc	21,173	$1,211,519
5	RPRX	Royalty Pharma plc	20,842	$1,168,610
6	XOMA	XOMA Royalty Corp	25,740	$1,093,950
7	TBPH	Theravance Biopharma, Inc.	59,096	$1,004,632

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,152,320	14,678	+5050.2%	Shares	Sole	2026-07-20
2026-03-31	$220,202	285	0.0%	Shares	Sole	2026-04-27
2025-12-31	$219,982	285	-51.3%	Shares	Sole	2026-02-06
2025-06-30	$307,125	585	0.0%	Shares	Sole	2025-08-12
2025-03-31	$371,024	585	0.0%	Shares	Sole	2025-05-12
2024-12-31	$416,713	585	0.0%	Shares	Sole	2025-02-13
2024-09-30	$614,975	585	0.0%	Shares	Sole	2024-11-13
2024-06-30	$614,852	585	0.0%	Shares	Sole	2024-08-09
2024-03-31	$563,056	585	-49.2%	Shares	Sole	2024-05-09
2023-12-31	$1,010,911	1,151	—	Shares	Sole	2024-02-22
No filing history on record for this holder in this stock.